About Helicobacter Pylori Diagnostics
Helicobacter pylori (H. pylori) is gram-negative, aerobic bacteria mostly found in the stomach. The bacterium plays an essential role in maintaining the stomach ecology. H. pylori infection is caused when spiral-shaped bacteria attacks the stomach lining. The bacterium is associated with gastritis and gastric ulcers. It is also linked to stomach cancer and duodenal ulcers. Most of the H. pylori infections are harmless, but these bacteria are also responsible for most of the stomach ulcers and small intestine infections.
Technavio’s analysts forecast the global helicobacter pylori diagnostics market to grow at a CAGR of 8.23% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global helicobacter pylori diagnostics market for 2017-2021. To calculate the market size, the report considers new installations, sales, volume, and value of H. pylori diagnostics market.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Helicobacter Pylori Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• F. Hoffmann-La Roche
Other prominent vendors
• Alpha Laboratories
• Biohit
• BIORON Diagnostics
• Certest Biotec
• Coris BioConcept
• Diagnostic Automation/Cortez Diagnostics
• Epitope Diagnostics
• Exalenz Bioscience
• ImevaX
• Labsystems Diagnostics
• Medline Industries
• Meridian Bioscience
• Mobidiag
• MP Biomedicals
• Omega Diagnostics Group
• Quest Diagnostics
• Quidel
• R-Biopharm
Market driver
• Rising prevalence of disease
• For a full, detailed list, view our report
Market challenge
• Competitive pricing pressure
• For a full, detailed list, view our report
Market trend
• Higher adoption rate of POC tests
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table Of Contents
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Market outline
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by technology
• Immunoassays
• POC
• Molecular diagnostics
PART 07: Market segmentation by end-user
• Hospitals and clinics
• Diagnostic laboratories
• Physicians' offices
PART 08: Geographical segmentation
• H. pylori diagnostics market in Americas
• H. pylori diagnostics market in EMEA
• H. pylori diagnostics market in APAC
PART 09: Decision framework
PART 10: Drivers and challenges
• Market drivers
• Market challenges
PART 11: Market trends
• Outsourcing from hospitals to reference laboratories
• Higher adoption rate of POC tests
• Introduction of automated multiplexed PCR assays
PART 12: Vendor landscape
• Competitive scenario
PART 13: Key vendor analysis
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• F. Hoffmann-La Roche
• Key companies to watch
• Other prominent vendors
PART 14: Appendix
• List of abbreviations
List of Exhibits
Exhibit 01: Global H. pylori diagnostics market 2016-2021: Overview
Exhibit 02: Global H. pylori diagnostics market 2016-2021 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Global H. pylori diagnostics market by technology 2016
Exhibit 05: Factors impacting immunoassays growth in H. pylori diagnostics market 2016 and 2021
Exhibit 06: Factors impacting POC growth in H. pylori diagnostics market 2016 and 2021
Exhibit 07: Factors impacting molecular diagnostics growth in H. pylori diagnostics market 2016 and 2021
Exhibit 08: Global H. pylori diagnostics market by end-users 2016: Overview
Exhibit 09: Factors impacting the end-users' product buying criteria
Exhibit 10: Global H. pylori diagnostics market by geography 2016-2021: Overview
Exhibit 11: H. pylori diagnostics market in Americas 2016-2021: Overview
Exhibit 12: H. pylori diagnostics market in Americas 2016-2021 ($ billions)
Exhibit 13: H. pylori diagnostics market in Americas 2016-2021: Country analysis
Exhibit 14: H. pylori diagnostics market in EMEA 2016-2021: Overview
Exhibit 15: H. pylori diagnostics market in EMEA 2016-2021 ($ billions)
Exhibit 16: H. pylori diagnostics market in EMEA 2016-2021: Country analysis
Exhibit 17: H. pylori diagnostics market in APAC 2016-2021: Overview
Exhibit 18: H. pylori diagnostics market in APAC 2016-2021 ($ billions)
Exhibit 19: H. pylori diagnostics market in APAC 2016-2021: Country analysis
Exhibit 20: Competitive structure analysis of global H. pylori diagnostics market 2016
Exhibit 21: Competitive landscape analysis of global H. pylori diagnostics market 2016
Exhibit 22: Strategic success factors of companies in global H. pylori diagnostics market
Exhibit 23: Thermo Fisher Scientific: Key highlights
Exhibit 24: Thermo Fisher Scientific: Strategy assessment
Exhibit 25: Thermo Fisher Scientific: Strategy assessment
Exhibit 26: Thermo Fisher Scientific: Opportunity assessment
Exhibit 27: Bio-Rad Laboratories: Key highlights
Exhibit 28: Bio-Rad Laboratories: Strength assessment
Exhibit 29: Bio-Rad Laboratories: Strategy assessment
Exhibit 30: Bio-Rad Laboratories: Opportunity assessment
Exhibit 31: F. Hoffmann-La Roche: Key highlights
Exhibit 32: F. Hoffmann-La Roche: Strength assessment
Exhibit 33: F. Hoffmann-La Roche: Strategy assessment
Exhibit 34: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 35: bioMérieux: Company assessment
Exhibit 36: BD: Company assessment
Exhibit 37: Alere: Company assessment
Exhibit 38: Cardinal Health: Company assessment
Exhibit 39: QIAGEN: Company assessment
